v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Cash Flows from Operating Activities    
Net (loss) income $ (3,190,203) $ 1,939,948
Adjustments to reconcile net (loss) income to net cash used in operating activities:    
Gain on cash (investments) held in Trust Account (584,665) (1,646,298)
Change in fair value of derivative warrant liabilities 3,639,376 (1,010,937)
Changes in operating assets and liabilities:    
Prepaid expenses (13,639) 27,996
Deferred legal fees 10,507 339,705
Accounts payable (49,114) 261,421
Due from related party 25,980  
Due to related party (165,000) 15,000
Accrued expenses (2,200) 48,554
Net cash used in operating activities (328,958) (24,611)
Cash Flows from Investing Activities    
Extension contribution deposit into Trust Account (270,000)
Net cash used in investing activities (270,000)
Cash Flows from Financing Activities    
Proceeds from Promissory note – working capital loan 401,000 23,420
Proceeds from Promissory note – extension loan 270,000
Net cash provided by financing activities 671,000 23,420
Net increase (decrease) in cash 72,042 (1,191)
Cash - beginning of period 1,173 1,253
Cash - end of period 73,215 62
Supplemental disclosure of noncash investing and financing activities:    
Remeasurement of Class A ordinary shares to redemption value 584,665 1,646,307
Extension contribution due from Sponsor $ 270,000 $ 480,000